Literature DB >> 19995842

Attention Network Test reveals alerting network dysfunction in multiple sclerosis.

Carsten Urbanek1, Nicholetta Weinges-Evers, Judith Bellmann-Strobl, Markus Bock, Jan Dörr, Eric Hahn, Andres H Neuhaus, Carolin Opgen-Rhein, Thi Minh Tam Ta, Katja Herges, Caspar F Pfueller, Helena Radbruch, Klaus D Wernecke, Stephanie Ohlraun, Frauke Zipp, Michael Dettling, Friedemann Paul.   

Abstract

Attention is one of the cognitive domains typically affected in multiple sclerosis. The Attention Network Test was developed to measure the function of the three distinct attentional networks, alerting, orienting, and executive control. The Attention Network Test has been performed in various neuropsychiatric conditions, but not in multiple sclerosis. Our objective was to investigate functions of attentional networks in multiple sclerosis by means of the Attention Network Test. Patients with relapsing-remitting multiple sclerosis (n = 57) and healthy controls (n = 57) matched for age, sex, and education performed the Attention Network Test. Significant differences between patients and controls were detected in the alerting network (p = 0.003), in contrast to the orienting (p = 0.696) and the conflict (p = 0.114) network of visual attention. Mean reaction time in the Attention Network Test was significantly longer in multiple sclerosis patients than in controls (p = 0.032), Multiple sclerosis patients benefited less from alerting cues for conflict resolution compared with healthy controls. The Attention Network Test revealed specific alterations of the attention network in multiple sclerosis patients which were not explained by an overall cognitive slowing.

Entities:  

Mesh:

Year:  2009        PMID: 19995842     DOI: 10.1177/1352458509350308

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  22 in total

1.  Information processing and magnetic resonance imaging indices of brain pathology in multiple sclerosis.

Authors:  Antonina Omisade; John D Fisk; Raymond M Klein; Matthias Schmidt; Sultan Darvesh; Virender Bhan
Journal:  Int J MS Care       Date:  2012

2.  Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases?

Authors:  Anja Mähler; Silvia Mandel; Mario Lorenz; Urs Ruegg; Erich E Wanker; Michael Boschmann; Friedemann Paul
Journal:  EPMA J       Date:  2013-02-18       Impact factor: 6.543

Review 3.  Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease management.

Authors:  Friedemann Paul; Jens Wuerfel; Tim Sinnecker; Joseph Kuchling; Petr Dusek; Jan Dörr; Thoralf Niendorf
Journal:  EPMA J       Date:  2015-08-27       Impact factor: 6.543

4.  Disentangling the attention network test: behavioral, event related potentials, and neural source analyses.

Authors:  Alejandro Galvao-Carmona; Javier J González-Rosa; Antonio R Hidalgo-Muñoz; Dolores Páramo; María L Benítez; Guillermo Izquierdo; Manuel Vázquez-Marrufo
Journal:  Front Hum Neurosci       Date:  2014-10-13       Impact factor: 3.169

5.  Low contrast visual acuity testing is associated with cognitive performance in multiple sclerosis: a cross-sectional pilot study.

Authors:  Laura Wieder; Gunnar Gäde; Luisa M Pech; Hanna Zimmermann; Klaus-Dieter Wernecke; Jan-Markus Dörr; Judith Bellmann-Strobl; Friedemann Paul; Alexander U Brandt
Journal:  BMC Neurol       Date:  2013-11-08       Impact factor: 2.474

Review 6.  The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue.

Authors:  Christian Veauthier; Helge Hasselmann; Stefan M Gold; Friedemann Paul
Journal:  EPMA J       Date:  2016-11-24       Impact factor: 6.543

7.  Deficits in Early Sensory and Cognitive Processing Are Related to Phase and Nonphase EEG Activity in Multiple Sclerosis Patients.

Authors:  Esteban Sarrias-Arrabal; Sara Eichau; Alejandro Galvao-Carmona; Elvira Domínguez; Guillermo Izquierdo; Manuel Vázquez-Marrufo
Journal:  Brain Sci       Date:  2021-05-13

8.  Selective impairment of attentional networks of alerting in Wilson's disease.

Authors:  Yongsheng Han; Fangfang Zhang; Yanghua Tian; Panpan Hu; Bo Li; Kai Wang
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

9.  Neural correlates of alerting and orienting impairment in multiple sclerosis patients.

Authors:  Manuel Vázquez-Marrufo; Alejandro Galvao-Carmona; Javier J González-Rosa; Antonio R Hidalgo-Muñoz; Mónica Borges; Juan Luis Ruiz-Peña; Guillermo Izquierdo
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

10.  Prefrontal tDCS Decreases Pain in Patients with Multiple Sclerosis.

Authors:  Samar S Ayache; Ulrich Palm; Moussa A Chalah; Tarik Al-Ani; Arnaud Brignol; Mohamed Abdellaoui; Dalia Dimitri; Marc Sorel; Alain Créange; Jean-Pascal Lefaucheur
Journal:  Front Neurosci       Date:  2016-04-08       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.